跳至主要内容
临床试验/CTRI/2024/03/064528
CTRI/2024/03/064528招募中Unknown

A prospective, observational, multicenter Real-World Evidence study to assess the effectiveness & safety of CIDMUS (sacubitril - valsartan) in Heart Failure with reduced Ejection Fraction (HFrEF) and Heart Failure with mid-range ejection fraction (HFmrEF) patients in India. - NA

Dr. Reddy’s Laboratories Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Male or female patients of Age greater or equal to 18 years
  • 2.Patients diagnosed with Heart Failure with Ejection fraction lessthan 50% at baseline, who were prescribed CIDMUS for the first time or within one week.
  • 3.Patients willing to provide consent to participate in the study

排除标准

  • 1. Contraindications to the study drug as per physician’s discretion.

研究者

相似试验